These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36566579)

  • 21. Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis.
    Smith JB; Gonzales EG; Li BH; Langer-Gould A
    JAMA Netw Open; 2022 Dec; 5(12):e2248664. PubMed ID: 36576740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the anti-COVID-19 vaccination campaign in the Metropolitan Area of Milan (Lombardy Region, Northern Italy).
    Russo AG; Tunesi S; Consolazio D; Decarli A; Bergamaschi W
    Epidemiol Prev; 2021; 45(6):568-579. PubMed ID: 34791867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital.
    Russo C; Tagliafico L; Labate L; Ponzano M; Mirabella M; Portunato F; Bellezza C; Mora S; Arboscello E; Monacelli F; Nencioni A; Signori A; Bruzzone B; Giacomini M; Dentone C; Bassetti M
    J Chemother; 2023 Dec; 35(8):730-736. PubMed ID: 37608747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System : A Target Trial Emulation Study.
    Ioannou GN; Locke ER; O'Hare AM; Bohnert ASB; Boyko EJ; Hynes DM; Berry K
    Ann Intern Med; 2022 Mar; 175(3):352-361. PubMed ID: 34928700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.
    Karlstad Ø; Hovi P; Husby A; Härkänen T; Selmer RM; Pihlström N; Hansen JV; Nohynek H; Gunnes N; Sundström A; Wohlfahrt J; Nieminen TA; Grünewald M; Gulseth HL; Hviid A; Ljung R
    JAMA Cardiol; 2022 Jun; 7(6):600-612. PubMed ID: 35442390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 cases, hospitalizations and deaths after vaccination: a cohort event monitoring study, Islamic Republic of Iran.
    Hosseinzadeh A; Sahab-Negah S; Nili S; Aliyari R; Goli S; Fereidouni M; Alami A; Shati M; Ahmadnezhad E; Mehravaran S; Fateh M; Khajeha H; Emamian Z; Behmanesh E; Mahdavi S; Enayatrad M; Mangolian Shahrbabaki P; Ansari-Moghaddam A; Heidarzadeh A; Shahraki-Sanavi F; Hashemi Shahri SM; Dehghan M; Amini Moridani M; Sheibani H; Abbaszadeh M; Jafari R; Valikhani M; Binesh E; Vahedi H; Chaman R; Khodashahi R; Amini M; Jabbari Azad F; Rezaeitalab F; Amel Jamehdar S; Eshraghi A; Sharifi H; Hashemi Bajgani SM; Mahdavi A; Jafarzadeh A; Farokhnia M; Ebrahimi S; Pardakhti A; Ghaderi E; Soltani H; Jadidoleslami S; Arianejad A; Gavili H; Moradveisi B; Motamedi D; Zare H; Kazemi T; Emamian MH
    Bull World Health Organ; 2022 Aug; 100(8):474-483. PubMed ID: 35923277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021.
    Wang W; Kaelber DC; Xu R; Berger NA
    JAMA Oncol; 2022 Jul; 8(7):1027-1034. PubMed ID: 35394485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 infection and hospitalization risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritis.
    Cordtz R; Kristensen S; Westermann R; Duch K; Pearce F; Lindhardsen J; Torp-Pedersen C; Andersen MP; Dreyer L
    Rheumatology (Oxford); 2022 Dec; 62(1):77-88. PubMed ID: 35416949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of habitual glucosamine use with SARS-CoV-2 infection and hospital admission and death with COVID-19: Evidence from a large population based cohort study.
    Meng M; Wu Y; Sha W; Zeng R; Luo D; Jiang R; Wu H; Zhuo Z; Yang Q; Li J; Leung FW; Duan C; Feng Y; Chen H
    J Med Virol; 2023 Apr; 95(4):e28720. PubMed ID: 37185863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
    Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB
    Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.
    Cegolon L; Negro C; Mastrangelo G; Filon FL;
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Sacco C; Del Manso M; Mateo-Urdiales A; Rota MC; Petrone D; Riccardo F; Bella A; Siddu A; Battilomo S; Proietti V; Popoli P; Menniti Ippolito F; Palamara AT; Brusaferro S; Rezza G; Pezzotti P; Fabiani M;
    Lancet; 2022 Jul; 400(10346):97-103. PubMed ID: 35780801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
    Husby A; Hansen JV; Fosbøl E; Thiesson EM; Madsen M; Thomsen RW; Sørensen HT; Andersen M; Wohlfahrt J; Gislason G; Torp-Pedersen C; Køber L; Hviid A
    BMJ; 2021 Dec; 375():e068665. PubMed ID: 34916207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection.
    Donato F; Pilotto A; Focà E; Tresoldi M; Tonoli A; Perani C; Minisci D; Salvetti M; Filippini M; Bezzi M; Em Boari G; Gipponi S; Stegher C; Nardin M; Caruso A; Metra M; Padovani A; Rossi C; Castelli F;
    Vaccine; 2024 Mar; 42(8):1863-1867. PubMed ID: 38355322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: A test-negative case-control study.
    Niessen FA; Knol MJ; Hahné SJM; ; Bonten MJM; Bruijning-Verhagen PCJL
    Vaccine; 2022 Aug; 40(34):5044-5049. PubMed ID: 35863935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.
    Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD
    BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.